RT Journal Article
SR Electronic
T1 Assessing the Impact of Haulage drivers in Uganda’s COVID-19 Delta Wave
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.09.10.24313441
DO 10.1101/2024.09.10.24313441
A1 Muwonge, Adrian
A1 Bessell, Paul R
A1 Bronsvoort, Mark Barend de Clare
A1 Mugerwa, Ibrahim
A1 Mwaka, Erisa
A1 Ssebaggala, Emmanuel
A1 Wee, Bryan Aidan
A1 Kiayias, Aggelos
A1 Mpyangu, Christine Mbabazi
A1 Joloba, Moses Lutakome
YR 2024
UL http://medrxiv.org/content/early/2024/09/12/2024.09.10.24313441.abstract
AB Background Haulage truck drivers can quickly connect distant communities, with risks of potential disease introduction. However, interventions to limit such risk must balance public health protection, economic continuity, and individual rights. Here distinguishing between their role in disease introduction and its onward spread is crucial for achieving this balance.Methods To investigate the role of haulage during the Delta wave of COVID-19 in Uganda. We fit a susceptible-infectious-recovered (SIR) model to the 625,422 records in the national surveillance dataset to assess the notion of a “core-risk group” by examining the incidence and impact of haulage-targeted interventions in border districts associated with heavy haulage traffic compared to the districts in the central region of Uganda.Results Although haulage drivers accounted for only 0.036% of the cases, the border districts associated with them registered 12.02% more cases than inland districts, suggesting a role in disease introduction. This risk was particularly higher in Tororo, compared to Amuru and Kyotera, which border Kenya, South Sudan, and Tanzania, respectively. Some interventions even increased the risk in Tororo by as much as 6%. However, in general, the haulage targeted interventions reduced the case load in border districts but registered limited impact on inland districts. This suggests a limited role in secondary within country spread. We note that combining such interventions with vaccination achieved greater reduction in case load.Conclusions Our findings suggest that truck drivers were a core risk group, though this risk was transient and in some cases exacerbated by some interventions. Pandemic preparedness strategies should characterize risks posed by core groups to ensure interventions balance public safety with individual rights in key sectors like supply chains.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementThe funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The research involving human participants underwent review and approval processes by several ethical committees, including the School of Public Health Higher Degrees, Research, and Ethics Committee at Makerere University (approval number SPH-2021-35), the Uganda National Council for Science and Technology (approval number HS156ES), and the Human Ethics and Research Committee at the Easter Bush Campus (HERC_538). The approvals included access to the national testing data as part of the THEA project. Written informed consent sought digitally was obtained from all participants prior to their inclusion in the study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe dataset use is available upon request from the Ministry of Health of Uganda